Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Disease Modifying Potential of a Sleep Intervention on Alzheimer's Disease (AD) Biomarkers

NCT03954899 is registered in ClinicalTrials.gov with Natalie Denburg as lead sponsor.

NCT NCT03954899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03954899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Disease Modifying Potential of a Sleep Intervention on Alzheimer's Disease (AD) Biomarkers
Lead sponsor
Natalie Denburg
Phase
Not applicable
Overall status
Recruiting
Start date
November 12, 2019
Completion date
February 29, 2028
Enrollment
230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive decline, healthy aging, mild cognitive impairment